MedPath

Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer

Conditions
Breast Cancer
Registration Number
NCT03568981
Lead Sponsor
Yonsei University
Brief Summary

This study aim to investigate the effect of 5-fraction stereotactic partial breast irradiation and whole breast irradiation on patient-reported outcomes, cosmetic outcome, and breast tissue fibrosis in early-stage breast cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Pathologically confirmed invasive breast carcinoma or ductal carcinoma in situ (DCIS)
  • Women who underwent breast-conservating surgery and have a plan to undergoing partial or whole breast irradiation
  • Good performance status (ECOG 0-1)
Exclusion Criteria
  • Recurrent breast cancer
  • History of ipsilateral breast irradiation
  • Positive resection margin status after breast surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of patient reported psychosocial functioning score2 year after radiotherapy (allowed to plus 8 weeks)

Patient reported psychosocial functioning measured in 7 point Likert scale

Change of patient reported patient treatment satisfaction score2 year after radiotherapy (allowed to plus 8 weeks)

Patient reported patient treatment satisfaction measured in 7 point Likert scale

Change of patient reported physical functioning score2 year after radiotherapy (allowed to plus 8 weeks)

Patient reported physical functioning measured in 7 point Likert scale

Change of patient reported body image score2 year after radiotherapy (allowed to plus 8 weeks)

Patient reported body image score measured in 7 point Likert scale

Change of breast cosmesis measures (excellent/good/poor)2 year after radiotherapy (allowed to plus 8 weeks)

breast cosmesis result is measures by BCCT.core (Breast Cancer Conservative Treatment cosmetic results) software

Change of breast-tissue fibrosis measures (gram)2 year after radiotherapy (allowed to plus 8 weeks)

breast-tissue fibrosis is measured by tissue compliance meter device.

Secondary Outcome Measures
NameTimeMethod
Incidence of Radiotherapy-related complications2 year after radiotherapy (allowed to plus 8 weeks)

Investigators will check whether there are any kinds of radiotherapy-related complications after PBI or WBI. Any differences of complications according to the radiotherapy techniques will be examed.

Trial Locations

Locations (1)

Severance Hospital

🇰🇷

Seoul, Korea, Korea, Republic of

Severance Hospital
🇰🇷Seoul, Korea, Korea, Republic of
YongBae Kim, MD
Contact
82-10-6256-2592
ybkim3@yuhs.ac

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.